MedTrace Logo

Cerebral Morbidity After Radiation Therapy for Brain Tumors

NCT04292353 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2021-05-05

No results posted yet for this study

Summary

This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of cognitive dysfunction. All types of brain tumours apart from glioblastoma will be included.

Conditions

Interventions

OTHER

Cognitive tests and Patient Reported Outcome

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Morten Høyer, M.D · Danish Center for Particel Therapy, Aarhus University Hospital, Denmark

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04292353 on ClinicalTrials.gov